tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLLS Stock Latest News

Cellectis files $200M mixed securities shelf
The FlyCellectis files $200M mixed securities shelf
8d ago
CLLS
Cellectis S.A. Announces Board Changes and Strategic Appointments
PremiumCompany Announcements
Cellectis S.A. Announces Board Changes and Strategic Appointments
14d ago
6K
CLLS
Cellectis Announces Board Changes Following Shareholders’ Meeting
PremiumCompany Announcements
Cellectis Announces Board Changes Following Shareholders’ Meeting
14d ago
6K
CLLS
Cellectis Announces Board Change and Key Shareholder Meeting Agenda
PremiumCompany Announcements
Cellectis Announces Board Change and Key Shareholder Meeting Agenda
2M ago
6K
CLLS
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
PremiumRatings
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
2M ago
CLLS
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
PremiumRatingsCellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
2M ago
CLLS
Cellectis price target lowered to $4 from $5 at Barclays
Premium
The Fly
Cellectis price target lowered to $4 from $5 at Barclays
2M ago
CLLS
Cellectis Reports Q1 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Cellectis Reports Q1 2025 Financial Results and Strategic Progress
2M ago
CLLS
Cellectis Reports Q1 2025 Financial Results and Strategic Developments
PremiumCompany Announcements
Cellectis Reports Q1 2025 Financial Results and Strategic Developments
2M ago
6K
CLLS
Cellectis S.A. Releases Q1 2025 Financial Results
PremiumCompany Announcements
Cellectis S.A. Releases Q1 2025 Financial Results
2M ago
6K
CLLS
Cellectis to Announce Q1 2025 Financial Results on May 12
PremiumCompany Announcements
Cellectis to Announce Q1 2025 Financial Results on May 12
2M ago
6K
CLLS
CLLS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CLLS Earnings this Week: How Will it Perform?
2M ago
CLLS
Cellectis Unveils Gene Editing Innovations at ASGCT Meeting
PremiumCompany AnnouncementsCellectis Unveils Gene Editing Innovations at ASGCT Meeting
2M ago
6K
CLLS
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
Premium
Company Announcements
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
3M ago
6K
CLLS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ALT
CLLS
Cellectis Reports 2024 Financial Results and Strategic Advances
PremiumCompany Announcements
Cellectis Reports 2024 Financial Results and Strategic Advances
4M ago
CLLS
Cellectis S.A. Earnings Call Highlights Strategic Growth
PremiumCompany Announcements
Cellectis S.A. Earnings Call Highlights Strategic Growth
4M ago
CLLS
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
PremiumRatings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
4M ago
CLLS
Cellectis reports Q4 EPS (64c) vs (17c) last year
PremiumThe Fly
Cellectis reports Q4 EPS (64c) vs (17c) last year
4M ago
AZN
CLLS
Cellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
PremiumCompany AnnouncementsCellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
5M ago
6K
CLLS
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
Premium
Market News
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
5M ago
NVS
CLLS
Cellectis files to sell 44M ordinary shares for holders
Premium
The Fly
Cellectis files to sell 44M ordinary shares for holders
6M ago
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >